minoxidil has been researched along with isoproterenol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andersson, O | 1 |
| Spilker, B; Tyll, J | 1 |
| Hanton, G; Lodola, A; Longeart, L | 1 |
| Evered, MD; Robinson, MM | 1 |
| Cohn, JN; Limas, CJ | 1 |
| Cohen, Y; Lindenbaum, A; Provost, Y; Wepierre, J | 1 |
| Harmsen, E; Leenen, FH; Ruzicka, M; Schoemaker, R; Yu, J | 1 |
1 review(s) available for minoxidil and isoproterenol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for minoxidil and isoproterenol
| Article | Year |
|---|---|
Management of hypertension. Clinical and hemodynamic studies with special reference to patients refractory to treatment.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Attitude to Health; Blood Pressure Determination; Clinical Trials as Topic; Diuretics; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Isoproterenol; Male; Middle Aged; Minoxidil; Outpatient Clinics, Hospital; Patient Participation; Plasma Volume; Sweden; Vascular Resistance; Vasodilator Agents | 1977 |
11 other study(ies) available for minoxidil and isoproterenol
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
On the question of tachyphylaxis to isoproterenol in guinea pigs.
Topics: Animals; Blood Pressure; Guinea Pigs; Heart Atria; Heart Rate; Hematocrit; Histamine; In Vitro Techniques; Isoproterenol; Lung; Minoxidil; Time Factors; Trachea | 1976 |
Cardiotoxicity of hydralazine and minoxidil in the rat. Influence of age.
Topics: Aging; Animals; Blood Pressure; Heart Diseases; Heart Rate; Hydralazine; Isoproterenol; Minoxidil; Myocardium; Necrosis; Rats; Rats, Inbred Strains | 1991 |
Pressor action of intravenous angiotensin II reduces drinking response in rats.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Diazoxide; Dose-Response Relationship, Drug; Drinking Behavior; Isoproterenol; Minoxidil; Rats; Thirst; Water-Electrolyte Balance | 1987 |
Stimulation of vascular smooth muscle sodium, potassium--adenosinetriphosphatase by vasodilators.
Topics: Adenosine Triphosphatases; Animals; Cyclic AMP; Diazoxide; Dogs; Epinephrine; Hydralazine; Hydrogen-Ion Concentration; Isoproterenol; Mesenteric Arteries; Minoxidil; Muscle, Smooth; Norepinephrine; Nucleotides; Polyphloretin Phosphate; Potassium; Propranolol; Prostaglandin Antagonists; Prostaglandins; Sodium; Stimulation, Chemical; Vasodilator Agents | 1974 |
Cardiovascular effects of dihydralazine diazoxide and minoxidil alone or associated with propranolol in renal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Diazoxide; Dihydralazine; Drug Interactions; Hemodynamics; Hypertension, Renal; Isoproterenol; Male; Minoxidil; Propranolol; Rats; Time Factors | 1981 |
Sensitivity to ischaemic ATP breakdown in different models of cardiac hypertrophy in rats.
Topics: Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Hyperemia; Hypertension; Isoproterenol; Male; Minoxidil; Myocardial Ischemia; Osmolar Concentration; Purines; Rats; Rats, Wistar; Time Factors | 1994 |